Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis.

Cell stem cell | 2018

Adequate availability of cellular building blocks, including lipids, is a prerequisite for cellular proliferation, but excess dietary lipids are linked to increased cancer risk. Despite these connections, specific regulatory relationships between membrane composition, intestinal stem cell (ISC) proliferation, and tumorigenesis are unclear. We reveal an unexpected link between membrane phospholipid remodeling and cholesterol biosynthesis and demonstrate that cholesterol itself acts as a mitogen for ISCs. Inhibition of the phospholipid-remodeling enzyme Lpcat3 increases membrane saturation and stimulates cholesterol biosynthesis, thereby driving ISC proliferation. Pharmacologic inhibition of cholesterol synthesis normalizes crypt hyperproliferation in Lpcat3-deficient organoids and mice. Conversely, increasing cellular cholesterol content stimulates crypt organoid growth, and providing excess dietary cholesterol or driving endogenous cholesterol synthesis through SREBP-2 expression promotes ISC proliferation in vivo. Finally, disruption of Lpcat3-dependent phospholipid and cholesterol homeostasis dramatically enhances tumor formation in Apcmin mice. These findings identify a critical dietary-responsive phospholipid-cholesterol axis regulating ISC proliferation and tumorigenesis.

Pubmed ID: 29395055 RIS Download

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK085535
  • Agency: NIDDK NIH HHS, United States
    Id: K01 DK114373
  • Agency: NIDDK NIH HHS, United States
    Id: RC2 DK118640
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK063491
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK041301
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK085532
  • Agency: NHLBI NIH HHS, United States
    Id: P01 HL030568

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Purified anti-mouse F4/80 (antibody)

RRID:AB_893504

This monoclonal targets F4/80

View all literature mentions

Purified anti-mouse Ly-6G (antibody)

RRID:AB_1089179

This monoclonal targets Ly-6G

View all literature mentions

Cleaved Caspase-3 (Asp175) Antibody (antibody)

RRID:AB_2341188

This polyclonal targets Cleaved Caspase-3 (Asp175)

View all literature mentions

SP-1 Chromogranin A (Porcine) Antibody (antibody)

RRID:AB_572226

This polyclonal targets porcine Chromogranin A

View all literature mentions

Olfm4 (D6Y5A) XP® Rabbit mAb (Mouse Specific) #39141 (antibody)

RRID:AB_2650511

This monoclonal targets endogenous levels of total mouse Olfm4 protein

View all literature mentions